| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $101.21M | - | |
| Dir | 1.55M | $80.02M | - | |
| Dir | 1.19M | $61.26M | - | |
| CFO | 1.12M | $57.56M | - | |
| VP | 594.7K | $30.64M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2021 | Wyszomierski Jack L | Director | Sale+OE | 6,220 | $22.64 | $140,820.80 | -2.6% | -18.4% | -0.4% | |
| Mar 15, 2021 | Garber Alan M50 | Director | Sale+OE | 40,000 | $23.60 | $944,000.00 | -75.9% | -5.8% | -16.0% | |
| Mar 1, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 65,000 | $22.11 | $1,437,150.00 | -16.0% | - | - | |
| Feb 24, 2021 | Cohen Charles | Director | Sale+OE | 40,000 | $22.69 | $907,600.00 | -18.1% | - | - | |
| Feb 23, 2021 | Willsey Lance | Director | Sale+OE | 90,000 | $21.91 | $1,972,136.00 | -6.6% | - | - | |
| Feb 22, 2021 | Marchesi Vincent T | Director | Sell | 24,097 | $22.29 | $537,122.13 | -26.7% | - | - | |
| Feb 18, 2021 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $22.43 | $2,242,500.00 | -8.5% | - | - | |
| Feb 16, 2021 | Feldbaum Carl B47 | Director | Sale+OE | 20,000 | $21.96 | $439,200.00 | -70.1% | - | - | |
| Feb 12, 2021 | Haley Patrick J.56 | EVP, Commercial | Sell | 45,000 | $21.57 | $970,650.00 | -15.4% | - | - | |
| Feb 1, 2021 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 65,000 | $22.08 | $1,435,200.00 | -18.7% | - | - |